Arabic Arabic English English French French German German
dark

Diversity in Clinical Trials: Learn about Enrollment Trends and Resources from FDA

FDA will share CDER’s most recent assessment of clinical trial diversity and discuss efforts to advance diverse participation in clinical trials including relevant FDA guidance and regulations.
Presenters:
Milena Lolic, M.D., M.S
CDER | FDA
Melvyn Okeke, M.P.H.
CDER | FDA
Kaveeta Vasisht, M.D., Pharm.D.
Associate Commissioner for Women’s Health | FDA
RADM Richardae Araojo, Pharm.D., M.S.
Associate Commissioner for Minority Health | FDA

Learn more at https://www.fda.gov/drugs/news-events-human-drugs/diversity-clinical-trials-learn-about-enrollment-trends-and-resources-fda-12162020-12162020
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming Training – https://www.fda.gov/cdersbia
SBIA Listserv – https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2020 Playlist – https://www.youtube.com/playlist?list=PLey4Qe-UxcxZiTopt4biuIyxmUQJDkaWb
SBIA 2021 Playlist – https://youtube.com/playlist?list=PLey4Qe-UxcxYS1MaTusSgyifQDqdeepyD
SBIA LinkedIn – https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
SBIA Training Resources – https://www.fda.gov/cderbsbialearn
Twitter – https://twitter.com/FDA_Drug_Info
Email – CDERSBIA@fda.hhs.gov
Phone – (301) 796-6707 I (866) 405-5367

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Action mechanism of Roman chamomile in the treatment of anxiety disorder based on network pharmacology.

Next Post

Traditional Chinese music therapy and painting therapy can promote the recovery of patients’ physical and psychological functions.

Related Posts
Total
0
Share